http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7123434-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-31 |
| filingDate | 2021-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-7123434-B1 |
| titleOfInvention | Osteoclast differentiation inhibitor |
| abstract | [PROBLEMS] To provide an osteoclast differentiation inhibitor useful for the prevention and treatment of metabolic bone diseases such as osteoporosis and rheumatoid arthritis. SOLUTION: An extract of watercress is used as an active ingredient. [Selection diagram] Fig. 1 |
| priorityDate | 2021-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.